DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Adamas Pharmaceuticals, Inc. (ADMS)
« Back to company indexADMS Chatter Timeline
Stock Ticker for ADMS
Most Active Tweeters for ADMS
| User | Tweets |
|---|---|
| @AmericanBanking | 9 |
| @Gambiste1 | 8 |
| @Tickeron | 6 |
| @newsfilterio | 5 |
| @OlympiaReport | 4 |
Recent Tweets for ADMS
 |
@TopStockAlerts1 $ADMS Liking it for a swing! November 10th 2019, 4:11pm |
 |
@ConsumerFeed Adamas Pharmaceuticals $ADMS Earns Buy Rating from Northland Securities https://t.co/PdW4fruVVL November 10th 2019, 4:11pm |
 |
@bbnsnews Adamas Pharmaceuticals $ADMS Rating Reiterated by Northland Securities https://t.co/btXDuojPyN November 10th 2019, 4:11pm |
 |
@BlueBioNow $ADMS might be worth taking a position when this bottoms 19.79 % change recently https://t.co/XRyA8PlkjA November 10th 2019, 2:11pm |
 |
@OlympiaReport Adamas Pharmaceuticals $ADMS Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS https://t.co/Zw9C74aKvK November 10th 2019, 1:11pm |
 |
@dispatchtribune Adamas Pharmaceuticals $ADMS Posts Quarterly Earnings Results, Misses Expectations By $0.09 EPS https://t.co/8tuhwg6Mnp November 10th 2019, 1:11pm |
 |
@Gambiste1 RT @newsfilterio: 25,000 shares acquired by Prentiss Christopher B (Chief Financial Officer) $ADMS https://t.co/snek0G7SNk November 10th 2019, 3:11am |
 |
@newsfilterio 25,000 shares acquired by Prentiss Christopher B (Chief Financial Officer) $ADMS https://t.co/snek0G7SNk November 10th 2019, 2:11am |
 |
@WatchlistN Adamas Pharmaceuticals $ADMS Given “Buy” Rating at Northland Securities https://t.co/rc9Kz1bYPH November 10th 2019, 12:11am |
|
@Gambiste1 RT @newsfilterio: Adamas Pharma EPS misses by $0.11, misses on revenue $ADMS https://t.co/gEKPw1Tm2G November 9th 2019, 11:11pm |
|
@Gambiste1 RT @newsfilterio: Mixed shelf roundup - healthcare $ADMS $DRNA https://t.co/RgOZMZwBtb November 9th 2019, 11:11pm |
|
@WatchlistN Adamas Pharmaceuticals $ADMS Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS https://t.co/zvJCzg9avM November 9th 2019, 6:11pm |
 |
@WeekHerald Adamas Pharmaceuticals $ADMS Stock Price Up 5.4% https://t.co/puxe97BC5s November 9th 2019, 5:11pm |
|
@OlympiaReport Adamas Pharmaceuticals $ADMS Trading 5.4% Higher https://t.co/07Oioo0t76 November 9th 2019, 5:11pm |
 |
@ZolmaxNews Adamas Pharmaceuticals $ADMS Issues Earnings Results https://t.co/NtRbRSzttY November 9th 2019, 5:11pm |
 |
@AmericanBanking Adamas Pharmaceuticals $ADMS Issues Earnings Results https://t.co/aXvssFVftQ #stocks November 9th 2019, 1:11pm |
 |
@dailypoliticaln Adamas Pharmaceuticals $ADMS Announces Earnings Results https://t.co/TSESPpAahu November 9th 2019, 1:11pm |
 |
@TickerReport Adamas Pharmaceuticals $ADMS Issues Earnings Results https://t.co/cQqkTeWjHd November 9th 2019, 1:11pm |
|
@Gambiste1 RT @gcassidy718: $ADMS reasonable changes in stock price 19.79 % change recently https://t.co/dvflrsAT2L November 9th 2019, 11:11am |
 |
@gcassidy718 $ADMS reasonable changes in stock price 19.79 % change recently https://t.co/dvflrsAT2L November 9th 2019, 11:11am |
|
@BlueBioNow $ADMS Stock is under performing. . . -3.62 % change recently https://t.co/XRyA8PlkjA November 8th 2019, 11:11pm |
|
@Gambiste1 RT @newsfilterio: Adamas Reports Third Quarter 2019 Financial Results $ADMS https://t.co/sCgBTTg5Wu November 8th 2019, 10:11pm |
 |
@ChartMill $ADMS has a better Quick Ratio than the average industry Quick Ratio of 4.90 https://t.co/L4kBwCLi6i https://t.co/M5povTDTTb November 8th 2019, 6:11pm |
|
@Gambiste1 RT @newsfilterio: Adamas Announces New Employment Inducement Grant $ADMS https://t.co/u8UpjnB2kG November 8th 2019, 6:11pm |
 |
@fm23 $ADMS https://t.co/ySNmXIq25F November 8th 2019, 5:11pm |
 |
@InsiderAlertsIA $ADMS: New Insider Filing on Chief Financial Officer CHRISTOPHER B PRENTISS: https://t.co/LOHjLWVz25 November 8th 2019, 5:11pm |
|
@AmericanBanking Adamas Pharmaceuticals $ADMS PT Lowered to $16.00 at JMP Securities https://t.co/defHZKtJQu #stocks November 8th 2019, 4:11pm |
|
@WatchlistN Adamas Pharmaceuticals $ADMS PT Lowered to $16.00 https://t.co/DzUFqwXEIu November 8th 2019, 4:11pm |
 |
@otcdynamics $ADMS Adamas Announces New Employment Inducement Grant https://t.co/ntU3TsGAAE November 8th 2019, 4:11pm |
|
@newsfilterio Adamas Announces New Employment Inducement Grant $ADMS https://t.co/u8UpjnB2kG November 8th 2019, 4:11pm |
|
@newsfilterio Mixed shelf roundup - healthcare $ADMS $DRNA https://t.co/RgOZMZwBtb November 8th 2019, 3:11pm |
 |
@ramypandey $adms from LOD to HOD is more than 40%. Wow November 8th 2019, 2:11pm |
 |
@LargeVoidBot 14:24 Pops: $ADMS +3.7% November 8th 2019, 2:11pm |
 |
@nodramahere7 $ADMS Nice pop here on strong volume! November 8th 2019, 1:11pm |
 |
@marketexclusive $ADMS Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Hold rating reiterated by Needham & Company LLC https://t.co/GSduKD9aBR #stocks November 8th 2019, 1:11pm |
|
@AmericanBanking Adamas Pharmaceuticals’ $ADMS “Hold” Rating Reaffirmed at Needham & Company LLC https://t.co/Ew2i9xtjKx #stocks November 8th 2019, 1:11pm |
|
@newsfilterio Adamas Pharma EPS misses by $0.11, misses on revenue $ADMS https://t.co/gEKPw1Tm2G November 8th 2019, 12:11pm |
|
@ramypandey Interesting run in $adms. Watching November 8th 2019, 11:11am |
|
@LargeVoidBot 10:36 Drops: $ADMS -6.0% November 8th 2019, 10:11am |
|
@Gambiste1 RT @Biotrade_alert: Trade Alert: Sold $ADMS at $4.32 with 1% Gain (2% Position) November 8th 2019, 10:11am |
 |
@Biotrade_alert Trade Alert: Sold $ADMS at $4.32 with 1% Gain (2% Position) November 8th 2019, 9:11am |
|
@AmericanBanking Adamas Pharmaceuticals $ADMS Stock Rating Reaffirmed by Northland Securities https://t.co/mLA2LjWlMU #stocks November 8th 2019, 9:11am |
 |
@AnalystWire Adamas Pharmaceuticals $ADMS PT Lowered to $11 at Piper Jaffray https://t.co/Dr3jz2R2M5 November 8th 2019, 9:11am |
|
@marketexclusive $ADMS Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by Northland Securities with a $15.00… https://t.co/u7XazZp58i November 8th 2019, 8:11am |
|
@TickerReport Northland Securities Reaffirms Buy Rating for Adamas Pharmaceuticals $ADMS https://t.co/D7tbF0UhJX November 8th 2019, 8:11am |
|
@dailypoliticaln Adamas Pharmaceuticals’ $ADMS Buy Rating Reiterated at Northland Securities https://t.co/aBYD6zXBo1 November 8th 2019, 8:11am |
|
@Gambiste1 RT @Tickeron: $ADMS's 10-day Moving Average broke below its 50-day Moving Average on October 3, 2019. View odds for this and other indicato… November 8th 2019, 5:11am |
 |
@Tickeron $ADMS's 10-day Moving Average broke below its 50-day Moving Average on October 3, 2019. View odds for this and othe… https://t.co/DPO4NwnmW4 November 8th 2019, 4:11am |
|
@newsfilterio Adamas Reports Third Quarter 2019 Financial Results $ADMS https://t.co/sCgBTTg5Wu November 8th 2019, 12:11am |
 |
@newswelldone $ADMS: Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q3 …: https://t.co/u8dpFNNOw6 November 7th 2019, 10:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.